C. Mukuria

发表

Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey.

J. Brazier, A. Tsuchiya, L. Longworth, 2014, Health technology assessment.

A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures.

S. Paisley, M. Barkham, J. Connell, 2014, Health technology assessment.

An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility Values

J. Brazier, D. Rowen, S. Harnan, 2019, Applied Health Economics and Health Policy.

Generation, Selection, and Face Validation of Items for a New Generic Measure of Quality of Life: The EQ Health and Wellbeing

J. Connell, J. Brazier, W. Greiner, 2022, Value in Health.

Olaparib for Maintenance Treatment of BRCA 1 or 2 Mutated, Relapsed, Platinum-Sensitive Ovarian, Fallopian Tube and Peritoneal Cancer in People Whose Relapsed Disease has Responded to Platinum-Based Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

P. Thokala, P. Tappenden, S. Ren, 2016, PharmacoEconomics.

Comparing EQ-5D-3L and EQ-5D-5L in measuring the HRQoL burden of 4 health conditions in China

C. Mukuria, Zhihao Yang, Guizhi Weng, 2022, The European Journal of Health Economics.

Chapter 4: Appendices

S. Paisley, M. Barkham, J. Connell, 2014 .

What is the evidence for the performance of generic preference-based measures? A systematic overview of reviews

J. Brazier, C. Mukuria, A. Finch, 2017, The European Journal of Health Economics.

Exploring the Issues of Valuing Child and Adolescent Health States Using a Mixed Sample of Adolescents and Adults

A. Wailoo, D. Rowen, C. Mukuria, 2022, PharmacoEconomics.

Sourcing and Using Appropriate Health State Utility Values in Economic Models in Health Care

S. Paisley, J. Brazier, D. Rowen, 2017, PharmacoEconomics.

Mapping the EQ-5D index from the cystic fibrosis questionnaire-revised using multiple modelling approaches

S. Acaster, C. Mukuria, B. Pinder, 2015, Health and Quality of Life Outcomes.

Examining productivity losses associated with health related quality of life using patient data

S. Dixon, D. Rowen, C. Mukuria, 2013 .

The Development of a New International Generic Measure (EQ Health and Wellbeing): Face Validity and Psychometric Stages in Argentina.

C. Mukuria, F. Augustovski, L. Gibbons, 2022, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Selecting Bolt-on Dimensions for the EQ-5D: Testing the Impact of Hearing, Sleep, Cognition, Energy, and Relationships on Preferences Using Pairwise Choices

J. Brazier, C. Mukuria, A. Finch, 2020, Medical decision making : an international journal of the Society for Medical Decision Making.

A qualitative investigation of the relevance of skin irritation and self-confidence bolt-ons and their conceptual overlap with the EQ-5D in patients with psoriasis

C. Mukuria, F. Rencz, A. Finch, 2022, Quality of Life Research.

Examining productivity losses associated with health related quality of life using patient and general population data

J. Brazier, C. Mukuria, R. Ara, 2013 .

Criteria for item selection for a preference-based measure for use in economic evaluation

J. Connell, J. Brazier, T. Peasgood, 2020, Quality of Life Research.

Mapping Functions in Health-Related Quality of Life

Donna Rowen, Tracey A. Young, Clara Mukuria, 2015, Medical decision making : an international journal of the Society for Medical Decision Making.

Valuing Health State: An EQ-5D-5L Value Set for Ethiopians.

Elly Stolk, Clara Mukuria, Murray D Krahn, 2020, Value in health regional issues.

Eliciting Societal Preferences for Weighting QALYs for Burden of Illness and End of Life

S. Whyte, P. Shackley, J. Brazier, 2016, Medical decision making : an international journal of the Society for Medical Decision Making.

Deriving a Preference-Based Measure for People With Duchenne Muscular Dystrophy From the DMD-QoL.

J. Brazier, R. Norman, D. Rowen, 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Developing a New Generic Health and Wellbeing Measure: Psychometric Survey Results for the EQ-HWB.

J. Bjorner, J. Brazier, A. Pickard, 2022, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Comparing EQ-5D-3L and EQ-5D-5L in measuring the HRQoL burden of 4 health conditions in China

N. Luo, C. Mukuria, Zhihao Yang, 2020, The European Journal of Health Economics.

Reliability and validity of using EQ-5D-5L among healthy and adolescents with major mental health disorders in Ethiopia

B. Sander, M. Krahn, G. B. Gebretekle, 2022, The European Journal of Health Economics.

A conceptual comparison of well-being measures used in the UK

J. Brazier, D. Rowen, T. Peasgood, 2014 .

Development of the CFQ-R-8D: Estimating Utilities From the Cystic Fibrosis Questionnaire-Revised.

S. Acaster, J. Brazier, A. Quittner, 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Developing an Australian utility value set for MacNew-7D health states

Gang Chen, D. Rowen, B. Mulhern, 2022, Quality of Life Research.

Development of a preference-based heart disease-specific health state classification system using MacNew heart disease-related quality of life instrument

P. Scuffham, J. Whitty, S. McPhail, 2021, Quality of Life Research.

An empirical comparison of well-being measures used in the UK

J. Brazier, D. Rowen, T. Peasgood, 2016 .

Deriving a Preference-Based Measure for Myelofibrosis from the EORTC QLQ-C30 and the MF-SAF.

J. Brazier, D. Rowen, T. Young, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Using generic preference-based measures in mental health: psychometric validity of the EQ-5D and SF-6D

M. Barkham, J. Brazier, M. Knapp, 2014, British Journal of Psychiatry.

A pragmatic randomised controlled trial assessing the non-inferiority of counselling for depression versus cognitive-behaviour therapy for patients in primary care meeting a diagnosis of moderate or severe depression (PRaCTICED): Study protocol for a randomised controlled trial

P. Bower, M. Barkham, J. Connell, 2017, Trials.

PMU86 - VALUING HEALTH-STATE: AN EQ-5D-5L VALUE SET FOR ETHIOPIANS

C. Mukuria, M. Krahn, G. Beedemariam, 2018, Value in Health.

The EQ Health and Wellbeing: Overview of the Development of a Measure of Health and Wellbeing and Key Results.

J. Connell, J. Brazier, A. Tsuchiya, 2022, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Selecting Bolt-On Dimensions for the EQ-5D: Examining Their Contribution to Health-Related Quality of Life.

J. Brazier, C. Mukuria, A. Finch, 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

An Exploratory Study on Using Principal-Component Analysis and Confirmatory Factor Analysis to Identify Bolt-On Dimensions: The EQ-5D Case Study.

J. Bjorner, J. Brazier, C. Mukuria, 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Valuing the EQ-5D and the SF-6D health states using subjective well-being: a secondary analysis of patient data.

J. Brazier, C. Mukuria, 2013, Social science & medicine.

Impact of social prescribing to address loneliness: A mixed methods evaluation of a national social prescribing programme.

S. Ariss, R. Jacques, C. Mukuria, 2020, Health & social care in the community.

Developing a health, social care and carer-related quality of life instrument to measure QALYs

J. Connell, J. Brazier, N. Devlin, 2018 .

A Systematic Review of the Methodologies and Modelling Approaches Used to Generate International EQ-5D-5L Value Sets

D. Rowen, C. Mukuria, E. McDool, 2022, PharmacoEconomics.

Systematic Review of the Effect of a One-Day Versus Seven-Day Recall Duration on Patient Reported Outcome Measures (PROMs)

T. Peasgood, C. Mukuria, Julia M. Caruana, 2023, The Patient - Patient-Centered Outcomes Research.

An evaluation of a new service model Improving Access to Psychological Therapies

P. Bower, M. Barkham, J. Connell, 2011 .

Article Title: Valuing the Eq-5d and the Sf-6d Health States Using Subjective Well-being: a Secondary Analysis of Patient Data Exploring the Relationship between Two Health State Classification Systems and Happiness Using a Large Patient Data Set

J. Brazier, C. Mukuria, 2022 .

What is the best approach to adopt for identifying the domains for a new measure of health, social care and carer-related quality of life to measure quality-adjusted life years? Application to the development of the EQ-HWB?

J. C. Rejon-Parrilla, J. Connell, J. Brazier, 2021, The European Journal of Health Economics.

Using preference based measures in mental health conditions: The psychometric validity of the EQ-5D and SF-6D

Brendan Mulhern, John Brazier, Djøra I. Soeteman, 2013 .

The Use of Mapping to Estimate Health State Utility Values

Donna Rowen, Clara Mukuria, Roberta Ara, 2017, PharmacoEconomics.

Assessing the comparative feasibility, acceptability and equivalence of videoconference interviews and face-to-face interviews using the time trade-off technique.

N. Bray, L. Longworth, D. Rowen, 2022, Social science & medicine.

Cost-effectiveness of an Improving Access to Psychological Therapies service

M. Barkham, J. Connell, J. Brazier, 2013, British Journal of Psychiatry.

Validation of 'Care Of the Dying Evaluation' (CODETM) within an international study exploring bereaved relatives' perceptions about quality of care in the last days of life.

D. Haugen, A. Keetharuth, C. Mayland, 2022, Journal of pain and symptom management.

Sensitivity and responsiveness of the EQ-5D-3L in patients with uncontrolled focal seizures: an analysis of Phase III trials of adjunctive brivaracetam

J. Brazier, A. Keetharuth, S. Borghs, 2016, Quality of Life Research.

A Comparison of the SF-6Dv2 and SF-6D UK Utility Values in a Mixed Patient and Healthy Population

J. Brazier, C. Mukuria, E. McDool, 2021, PharmacoEconomics.

Qualitative Review on Domains of Quality of Life Important for Patients, Social Care Users, and Informal Carers to Inform the Development of the EQ-HWB.

J. Connell, J. Brazier, A. Scope, 2022, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Predicting Productivity Losses from Health-Related Quality of Life Using Patient Data

S. Dixon, D. Rowen, C. Mukuria, 2017, Applied Health Economics and Health Policy.

Measuring the Burden of Schizophrenia Using Clinician and Patient-Reported Measures: An Exploratory Analysis of Construct Validity

J. Brazier, M. Franklin, S. Watson, 2019, The Patient - Patient-Centered Outcomes Research.

Should We Consider Including a Value for "Hope" as an Additional Benefit Within Health Technology Assessment?

A. Tsuchiya, A. Wailoo, D. Rowen, 2022, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Chapter 6 appendices

S. Paisley, M. Barkham, J. Connell, 2014 .

Estimating informal care inputs associated with EQ-5D for use in economic evaluation

S. Dixon, D. Rowen, C. Mukuria, 2016, The European Journal of Health Economics.

Does the generic cancer outcome measure eortc qlq-c30 work in myelofibrosis?

J. Brazier, R. Rafia, C. Mukuria, 2015 .

Comparison of Modes of Administration and Alternative Formats for Eliciting Societal Preferences for Burden of Illness

J. Brazier, A. Tsuchiya, A. Keetharuth, 2015, Applied Health Economics and Health Policy.

Title: Update: Eliciting societal preferences for weighting QALYs according to burden of illness, size of gain and end of life

S. Whyte, P. Shackley, J. Brazier, 2014 .

Therapies service Cost-effectiveness of an Improving Access to Psychological

M. Barkham, J. Connell, J. Brazier, 2014 .

Comparing EQ-5D-3L and EQ-5D-5L in measuring the HRQoL burden of 4 health conditions in China

N. Luo, C. Mukuria, Zhihao Yang, 2022, The European Journal of Health Economics.

Eliciting Societal Preferences for Weighting QALYs for Burden of Illness and End of Life

S. Whyte, P. Shackley, J. Brazier, 2016, Medical decision making : an international journal of the Society for Medical Decision Making.

Mapping functions for the PHQ-9 and GAD-7 to generate EQ-5D-3L for economic evaluation.

S. Hinde, C. Mukuria, Matthew Franklin, 2024, The European journal of health economics : HEPAC : health economics in prevention and care.

Psychometric performance of the CFQ-R-8D compared to the EQ-5D-3L and SF-6D in people with cystic fibrosis

A. Quittner, P. Sosnay, C. Mukuria, 2024, Journal of patient-reported outcomes.

Cost-effectiveness of an Improving Access to Psychological Therapies service

M. Barkham, J. Connell, J. Brazier, 2013, British Journal of Psychiatry.

Who should value children’s health and how? An international Delphi study

A. Keetharuth, C. Mukuria, Donna Rowen, 2024, Social Science & Medicine.

Understanding UK public views on normative decisions made to value health-related quality of life in children: A qualitative study.

A. Keetharuth, D. Rowen, C. Mukuria, 2023, Social science & medicine.

Developing Content for a New Generic Qaly Measure: Results from a Qualitative Literature Review (E-Qaly Project)

J. Connell, J. Brazier, A. Scope, 2018 .